Management of Non-clear Cell Renal Carcinoma

机译：非透明细胞肾癌的管理

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

In 2010 an estimated 58,000 new cases of renal cell carcinoma (RCC) will be diagnosed in the United States, and 13,000 people will die of this disease. RCC is made up of several different cancer subtypes, each of which has distinct molecular underpinnings and likely different responses to treatment. Major subtypes of RCC include clear cell, papillary types 1 and 2 chromophobe, and collecting duct cancers. In recent years improved understanding of RCC biology has translated into major advances in the treatment of patients with clear cell RCC. However, despite similar advances in the understanding of the biologic basis of various non-clear cell RCCs, much less clinical data are available to guide the treatment of patients with these less common tumors.

机译：2010年，估计58,000例新肾细胞癌（RCC）病例将在美国诊断，13,000人将死于这种疾病。 RCC由几种不同的癌症亚型组成，每个癌症亚型具有不同的分子支撑性和对治疗的可能反应。 RCC的主要亚型包括透明细胞，乳头状1和2发色面，以及收集管道癌。近年来，改善对RCC生物学的理解已转化为治疗透明细胞RCC患者的重大进展。然而，尽管了解对各种非透明细胞RCC的生物学基础的理解类似，但临床数据的临床资料得多以指导患有这些较差的常见肿瘤的患者。

著录项

来源
《Genitourinary Cancers Symposium》|2011年||共3页
会议地点
作者
Michael B. Atkins;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类泌尿生殖器肿瘤;
关键词

相似文献

外文文献
中文文献
专利

1. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma [J] . Jhaveri Kartik S., Elmi Azadeh, Hosseini-Nik Hooman, AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences . 2015,第1期

机译：化学位移MRI在区分透明细胞肾细胞癌和非透明细胞肾细胞癌与最小脂肪血管肌脂瘤中的预测价值
2. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma [J] . Jhaveri Kartik S., Elmi Azadeh, Hosseini-Nik Hooman, AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences . 2015,第1期

机译：化学位移MRI在区分透明细胞肾细胞癌和非透明细胞肾细胞癌与最小脂肪血管肌脂瘤中的预测价值
3. Non-clear cell renal cell carcinoma: clinico-biological characteristics and therapeutic management except surgery [J] . Thouvenin Jonathan, Barthelemy Philippe, Ladoire Sylvain Bulletin du Cancer: Journal de l'Association Francaise pour l'Etude du Cancer . 2020,第5Suppla期

机译：非透明细胞肾细胞癌：临床生物学特性和治疗管理除外手术
4. Management of Non-clear Cell Renal Carcinoma [C] . Michael B. Atkins Genitourinary Cancers Symposium . 2011

机译：非透明细胞肾癌的管理
5. Integrated Molecular Analysis for the Identification and Validation of Novel Biomarkers for Renal Cell Carcinoma and the Small Renal Mass [D] . Di Meo, Ashley . 2019

机译：肾细胞癌新生物标志物的鉴定和验证综合分子分析及小肾肿块
6. Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry [O] . Jung Kwon Kim, Sung Han Kim, Mi Kyung Song, 2019

机译：国际转移性肾细胞癌数据库联盟和纪念斯隆·凯特琳癌症中心风险模型在转移性非透明细胞肾细胞癌患者中的应用：使用韩国转移性肾细胞癌注册中心的多机构回顾性研究
7. Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours [O] . Karlo, Christoph A, Kou, Lei, Di Paolo, Pier Luigi, 2016

机译：肾细胞癌：包括CT成像在内的惰性，非透明细胞肾皮质肿瘤的诺模图预测

Management of Non-clear Cell Renal Carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅